{"organizations": [], "uuid": "38245293a8a12a1b1e05ba60c1c0edd69c7e053c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/markets/bonds", "section_title": "Rates ", "url": "https://www.reuters.com/article/brief-cidara-announces-stock-and-warrant/brief-cidara-announces-stock-and-warrants-offering-worth-120-mln-idUSASC0A30G", "country": "US", "domain_rank": 408, "title": "BRIEF-Cidara Announces Stock And Warrants Offering Worth $120 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-21T20:03:00.000+03:00", "replies_count": 0, "uuid": "38245293a8a12a1b1e05ba60c1c0edd69c7e053c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-cidara-announces-stock-and-warrant/brief-cidara-announces-stock-and-warrants-offering-worth-120-mln-idUSASC0A30G", "ord_in_thread": 0, "title": "BRIEF-Cidara Announces Stock And Warrants Offering Worth $120 Mln", "locations": [], "entities": {"persons": [{"name": "cidara", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "cidara therapeutics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 21 (Reuters) - Cidara Therapeutics Inc:\n* CIDARA THERAPEUTICS ANNOUNCES OFFERING OF COMMON STOCK AND WARRANTS\n* CIDARA THERAPEUTICS - ENTERED SECURITIES PURCHASE DEAL WITH CERTAIN INVESTORS PROVIDING FOR PURCHASE, SALE OF UP TO $120 MILLION OF ITS COMMON STOCK\n* CIDARA THERAPEUTICS INC - CIDARA WILL OFFER ABOUT 10.6 MILLION SHARES OF COMMON STOCK IN FIRST CLOSING OF OFFERING AT $4.70 PER SHARE\n* CIDARA THERAPEUTICS - ENTERED SECURITIES PURCHASE AGREEMENT FOR PURCHASE &SALE, OF UP TO AGGREGATE OF $120.0 MILLION OF ITS COMMON STOCK, IN 3 CLOSINGS\n* CIDARA - ALSO SELLING TO MAJOR PURCHASERS WARRANTS, AT $0.125/SHARE SUBJECT TO EACH SUCH WARRANT, TO PURCHASE AGGREGATE 12.5 MILLION SHARES OF STOCK Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-21T20:03:00.000+03:00", "crawled": "2018-05-21T16:02:15.026+03:00", "highlightTitle": ""}